Studies on the antiplatelet and antithrombotic profile of anti-inflammatory coumarin derivatives

References

• Sattari M, Lowenthal DT. Novel oral anticoagulants in development: Dabigatran, Rivaroxaban, and Apixaban. Am J Ther 2011;18:332–8
   PubMed Web of Science ®Google Scholar
• Alvarez R, Taylor A, Fazzari JJ, Jacobs JR. Regulation of cyclic AMP metabolism in human platelets. Sequential activation of adenylate cyclase and cyclic AMP phosphodiesterase by prostaglandins. Mol Pharmacol 1981;20:302–9
   PubMed Web of Science ®Google Scholar
• Tani T, Sakurai K, Kimura Y, et al. Pharmacological manipulation of tissue cyclic AMP by inhibitors. Effects of phosphodiesterase inhibitors on the functions of platelets and vascular endothelial cells. Adv Second Messenger Phosphoprotein Res 1992;25:215–27
   PubMedGoogle Scholar
• Angiolillo DJ. The evolution of antiplatelet therapy in the treatment of acute coronary syndromes: from aspirin to the present day. Drugs 2012;72:2087–116
   PubMed Web of Science ®Google Scholar
• Wijeyeratne YD, Heptinstall S. Anti-platelet therapy: ADP receptor antagonists. Br J Clin Pharmacol 2011;72:647–57
   PubMed Web of Science ®Google Scholar
• Schneider DJ. Anti-platelet therapy: glycoprotein IIb-IIIa antagonists. Br J Clin Pharmacol 2011;72:672–82
   PubMed Web of Science ®Google Scholar
• Rondina MT, Weyrich AS. Targeting phosphodiesterases in anti-platelet therapy. Handb Exp Pharmacol 2012;210:225–38
   PubMedGoogle Scholar
• Egan D, O'Kennedy R, Moran E, et al. The pharmacology, metabolism, analysis, and applications of coumarin and coumarin-related compounds. Drug Metab Rev 1990;22:503–29
   PubMed Web of Science ®Google Scholar
• Kimura Y, Tani T, Kanbe T, Watanabe K. Effect of cilostazol on platelet aggregation and experimental thrombosis. Arzneimittelforschung 1985;35:1144–9
   PubMed Web of Science ®Google Scholar
• Murray RDH, Mendez I, Brawn SA. The natural coumarins. New York: Wiley; 1982
   Google Scholar
• Catto M, Pisani L, Leonetti F, et al. Design, synthesis and biological evaluation of coumarin alkylamines as potent and selective dual binding site inhibitors of acetylcholinesterase. Bioorg Med Chem 2013;21:146–52
   PubMed Web of Science ®Google Scholar
• Fylaktakidou KC, Hadjipavlou-Litina DJ, Litinas KE, Nicolaides DN. Natural and synthetic coumarin derivatives with anti-inflammatory/antioxidant activities. Curr Pharm Des 2004;10:3813–33
   PubMed Web of Science ®Google Scholar
• Wilkinson P. New oral anticoagulants: an alternative to warfarin. Br J Hosp Med (Lond) 2012;7:498–501
   Google Scholar
• Deitelzweig S, Jaff MR. Medical management of venous thromboembolic disease. Tech Vasc Interv Radiol 2004;7:63–7
   PubMedGoogle Scholar
• Pochet L, Doucet C, Schynts M, et al. Esters and amides of 6-(chloromethyl)-2-oxo-2H-1-benzopyran-3-carboxylic acid as inhibitors of alpha-chymotrypsin: significance of the “aromatic” nature of the novel ester-type coumarin for strong inhibitory activity. J Med Chem 1996;39:2579–85
   PubMed Web of Science ®Google Scholar
• Pochet L, Doucet C, Dive G, et al. Coumarinic derivatives as mechanism-based inhibitors of alpha-chymotrypsin and human leukocyte elastase. Bioorg Med Chem 2000;8:1489–501
   PubMed Web of Science ®Google Scholar
• Wouters J, Huygens M, Pochet L, et al. Structural approach of the mechanism of inhibition of alpha-chymotrypsin by coumarins. Bioorg Med Chem Lett 2002;12:1109–12
   PubMed Web of Science ®Google Scholar
• Frédérick R, Robert S, Charlier C, et al. 3,6-Disubstituted coumarins as mechanism-based inhibitors of thrombin and factor Xa. J Med Chem 2005;48:7592–603
   PubMed Web of Science ®Google Scholar
• Bruno O, Brullo C, Schenone S, et al. Synthesis, antiplatelet and antithrombotic activities of new 2-substituted benzopyrano[4,3-d]pyrimidin-4-cycloamines and 4-amino/cycloamino-benzopyrano[4,3-d]pyrimidin-5-ones. Bioorg Med Chem 2006;14:121–30
   PubMed Web of Science ®Google Scholar
• Bruno O, Brullo C, Schenone S, et al. Synthesis and pharmacological evaluation of 5H-[1]benzopyrano[4,3-d]pyrimidines effective as antiplatelet/analgesic agents. Bioorg Med Chem 2004;12:553–61
   PubMed Web of Science ®Google Scholar
• Roma G, Cinone N, Di Braccio M, et al. Synthesis, antiplatelet activity and comparative molecular field analysis of substituted 2-amino-4H-pyrido[1,2-a]pyrimidin-4-ones, their congeners and isosteric analogues. Bioorg Med Chem 2000;8:751–68
   PubMed Web of Science ®Google Scholar
• Kontogiorgis CA, Hadjipavlou-Litina DJ. Synthesis and antiinflammatory activity of coumarin derivatives. J Med Chem 2005;48:6400–8
   PubMed Web of Science ®Google Scholar
• Kontogiorgis CA, Hadjipavlou-Litina DJ. Synthesis and biological evaluation of novel coumarin derivatives with a 7-azomethine linkage. Bioorg Med Chem Lett 2004;14:611–14
   PubMed Web of Science ®Google Scholar
• Kontogiorgis CA, Savvoglou K, Hadjipavlou-Litina DJ. Antiinflammatory and antioxidant evaluation of novel coumarin derivatives. J Enzyme Inhib Med Chem 2006;21:21–9
   PubMed Web of Science ®Google Scholar
• Kontogiorgis CA, Hadjipavlou Litina D. Nitric oxide release from coumarin-7-azomethine derivatives in the presence of thiol. Arzneimittelforschung 2007;57:143–6
   PubMed Web of Science ®Google Scholar
• Born GV. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 1962;194:927–9
   PubMed Web of Science ®Google Scholar
• Bellavite P, Andrioli G, Guzzo P, et al. A colorimetric method for the measurement of platelet adhesion in microtiter plates. Anal Biochem 1994;216:444–50
   PubMed Web of Science ®Google Scholar
• Davidson I, Henry JB. Clinical diagnosis of laboratory methods. 15th ed. Philadelphia: WB Sanders Company;1974:438–9
   Google Scholar
• Apodaca R, Dvorak CA, Xiao W, et al. A new class of diamine-based human histamine H3 receptor antagonists: 4-(aminoalkoxy)benzylamines. J Med Chem 2003;46:3938–44
   PubMed Web of Science ®Google Scholar
• Denizot F, Lang R. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods 1986;89:271–7
   PubMed Web of Science ®Google Scholar
• Nicolotti O, Carotti A. QSAR and QSPR studies of a highly structured physicochemical domain. J Chem Inf Model 2006;46:264–76
   PubMed Web of Science ®Google Scholar
• Nicolotti O, Benfenati E, Carotti A, et al. REACH and in silico methods: an attractive opportunity for medicinal chemists. Drug Disc Today 2014;19:1757–68
   PubMed Web of Science ®Google Scholar
• Gissi A, Gadaleta D, Floris M, et al. An alternative QSAR-based approach for predicting the bioconcentration factor for regulatory purposes. Altex 2014;31:23–36
   PubMed Web of Science ®Google Scholar
• C-QSAR, version 4 31. Claremont (CA): Biobyte Corp.; 2003. Available from: www.biobyte.com [last accessed Nov 2013]
   Google Scholar
• Hansch C, Leo AJ. Exploring QSAR fundamentals and applications in chemistry and biology. In: Heller SR, ed. ACS Professional Reference Book. Washington DC: American Chemical Society. 1995:279–80
   Google Scholar
• Cramer RD, Patterson DE, Bunce JD. Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. J Am Chem Soc 1988;110:5959–67
   PubMed Web of Science ®Google Scholar
• SPARTAN SGI, version 5.1.3 OpenGL. Irvine (CA): Wavefunction, Inc
   Google Scholar
• Dewar MJS, Zoebisch EG, Healy EF, Stewart JJP. Development and use of quantum mechanical molecular models. 76.AM1: a new general purpose quantum mechanical molecular model. J Am Chem Soc 1985;107:3902–9
   Web of Science ®Google Scholar
• Halggren TA. Merck molecular force field I. Basis, form, scope, parameterization and performance of MMFF94. J Comput Chem 1996;17:490–519
   Web of Science ®Google Scholar
• Stewart JJP. Optimization of parameters for semi-empirical methods I-Method. J Comp Chem 1989;10:209–20
   Web of Science ®Google Scholar
• Scapin G, Patel SB, Chung C, et al. Crystal structure of human phosphodiesterase 3B: atomic basis for substrate and inhibitor specificity. Biochemistry 2004;43:6091–100
   PubMed Web of Science ®Google Scholar
• http://www.pdb.org
   Google Scholar
• USCF CHIMERA. University of California, San Francisco, CA, USA; 1994. Available from: http://www.cgl.ucsf.edu/chimera [last accessed 10 Feb 2010]
   Google Scholar
• Lindorff Larsen K, Piana S, et al. Improved side-chain torsion potentials for the Amber ff99SB protein force field. Proteins 2010;78:1950–8
   PubMed Web of Science ®Google Scholar
• Wang J, Wolf RM, Caldwell JW, et al. Development and testing of a general amber force field. J Comput Chem 2004;25:1157–74
   PubMed Web of Science ®Google Scholar
• OpenBabel, version 2.2.3, Open Source Chemistry Toolbox. OELib Cheminformatics Company, USA; 2006. Available from: http://sourceforge.net/projects/openbabel [last accessed 10 Feb 2010]
   Google Scholar
• Autodock Vina v. 1.1.1., The Scripps Research Institute, San Diego, CA, USA; 2010. Copyright© 1989–2010
   Google Scholar
• Jin J, Kunapuli SP. Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregation. Proc Natl Acad Sci USA 1998;95:8070–4
   PubMed Web of Science ®Google Scholar
• Nurtjahja-Tjendraputra E, Ammit AJ, Roufogalis BD, et al. Effective anti-platelet and COX-1 enzyme inhibitors from pungent constituents of ginger. Thromb Res 2003;111:259–65
   PubMed Web of Science ®Google Scholar
• Eisert WG. Near-field amplification of antithrombotic effects of dipyridamole through vessel wall cells. Neurology 2001;57:S20–3
   Web of Science ®Google Scholar
• Nicolotti O, Giangreco I, Miscioscia TF, Carotti A. Improving quantitative structure-activity relationships through multiobjective optimization. J Chem Inf Model 2009;49:2290–302
   PubMed Web of Science ®Google Scholar